Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194935 · ClinicalTrials.gov registry record · Phase 2
Weekly Topotecan Therapy in Patients With Ovarian Cancer
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00194935 is a Phase 2 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 32 participants.
The verdict
NCT00194935, a Phase 2 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the safety and feasibility of weekly topotecan consolidation therapy in patients with ovarian cancer.
Interventions
- DRUG Topotecan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194935
The ClinicalTrials.gov registry entry for NCT00194935 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topotecan is the first listed.
NCT00194935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194935 about?
NCT00194935 is a clinical study titled "Weekly Topotecan Therapy in Patients With Ovarian Cancer". The purpose of this study is to find out the safety and feasibility of weekly topotecan consolidation therapy in patients with ovarian cancer.
What is the current status of trial NCT00194935?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2003-02. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00194935?
The interventions under investigation include: Topotecan (DRUG).
Who is sponsoring clinical trial NCT00194935?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.